Tata Digital-owned online pharmacy 1mg saw its consolidated turnover zoom 20% in the financial year ending March 2025 (FY25) to INR 2,392 Cr from INR 1,968 Cr in the previous fiscal, according to Tata Sons' annual report for the fiscal year.

The continued growth in 1mg’s revenue can be attributed to strong consumer adoption of e-pharmacy and digital healthcare services, particularly post Covid-19, and deeper category expansion.

1mg also benefits from Tata’s ecosystem integration, with cross-selling on Tata Neu helping boost order volumes.

Meanwhile, Tata Cliq, the fashion ecommerce platform of the Tata Group, reported a 19.2% rise in its turnover to INR 294.4 Cr in FY25 from INR 247 Cr in FY24. Net loss declined 24.4% to INR 314.2 Cr from INR 391 Cr in the previous fiscal year.

The growth in revenue came as the platform expanded its brand portfolio in FY25. However, Tata Cliq continues to face high competition from Myntra and Reliance's AJIO in the premium tier.

Croma, the omnichannel consumer electronics and goods subsidiary, reported a 7% rise in its turnover to INR 19,063.8 Cr from INR 17,817 Cr in FY24. However, its net loss also increased about 11% to INR 1,090.8 Cr from INR 982 Cr in the previous year.

Meanwhile, BigBasket, Tata Digital's quick commerce arm, saw its annual revenue fall in the financial year ending March 2025, amid intense competition in the segment. BigBasket's B2C arm, Innovative Retail Concepts, saw a 3% drop in turnover to INR 7,673 Cr in FY25 from INR 7,885 Cr in FY24. Its net loss also increased 46% to INR 1,851 Cr from INR 1,267 Cr in the previous year.

BigBasket's B2B unit, Supermarket Grocery Supplies, saw a sharper 7% fall in revenue to INR 2,227 Cr during the year under review from INR 2,391.8 Cr in FY24. However, its net loss also declined 20.2% to INR 102.2 Cr in FY25 from INR 128.1 Cr in the previous fiscal year.